secwatch.observer — SEC 8-K summary
======================================

Issuer:     NORTHWEST BIOTHERAPEUTICS INC (NWBO)
CIK:        0001072379
Form:       8-K
Filed at:   2024-06-04T23:59:59+00:00
Accession:  0001104659-24-068314
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Northwest Biotherapeutics sells 8.125M shares at $0.40 to SIO Capital for $3.25M
--------------------------------------------------------------------------------

- SPA signed June 4, 2024; closing expected June 5, 2024.
- Gross proceeds of $3,250,000 from sale of 8,125,000 shares of common stock.
- Proceeds to be used for ongoing business operations.
- SIO Capital Management LLC is the purchaser; Joseph Gunnar & Co. acted as placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924068314/0001104659-24-068314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1072379/000110465924068314/tm2416435d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-068314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer